Non-small Cell Lung Cancer Trials

Study 1 Description

A Phase III, Randomized, Double-Blind, Placebo-Controlled an investigational biotherapy medication in Combination with Docetaxel in Second-Line Treatment of Patients with Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)

Study 2 Description

Phase II trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70

Study 3 Description

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of an investigational biotherapy medication in combination with Paclitaxel and Carboplatin as First-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)

Study 4 Description

Phase 3 study of Pemetrexed plus Carboplatin and Bevacizumab followed by maintenance Pemetrexed and Bevacizumab versus Paclitaxel plus Carboplatin and Bevacizumab followed by Bevacizumab as First-Line Treatment in patients with stage 3B or stage 4 Non-Squamous Non-Small Cell Lung Cancer.

For additional information about Highline's Cancer Care Program, call (206) 439-5577.